aod9604 human clinical trial weight loss results kg or percent AOD-9604 Results: Week-by-Week Timeline (2026) π¨ 70 pounds. That's the
70 pounds. That's the average weight loss adults with obesity saw on the highest dose of an investigational once weekly Lilly medicine in a new Phase 3 study over 18 months. Nearly New insights into FGF21 hormone for weight loss AOD9604 Peptide for Fat Loss: Mechanism, Benefits & Risks Explained PDF] Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans Semantic Scholar
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 2 - Aug 7

